Vapreotide
Clinical data | |
---|---|
Trade names | Sanvar |
Other names | H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2 Octastatin |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 30 minutes |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
PubChem SID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C57H70N12O9S2 |
Molar mass | 1131.38 g·mol−1 |
3D model (JSmol) | |
Density | 1.4 g/cm3 |
Boiling point | 1,540.9 °C (2,805.6 °F) |
| |
|
Vapreotide (Sanvar) is a synthetic somatostatin analog. It is used in the treatment of esophageal variceal bleeding[1][2] in patients with cirrhotic liver disease and AIDS-related diarrhea.[3]
It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.
References[]
- ^ Calès P (April 2008). "Vapreotide acetate for the treatment of esophageal variceal bleeding". Expert Review of Gastroenterology & Hepatology. 2 (2): 185–92. doi:10.1586/17474124.2.2.185. PMID 19072353.
- ^ Fortune BE, Jackson J, Leonard J, Trotter JF (October 2009). "Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding". Expert Opinion on Pharmacotherapy. 10 (14): 2337–42. doi:10.1517/14656560903207019. PMID 19708854.
- ^ DrugBank DB04894
Categories:
- Antineoplastic drugs
- Lactams
- Peptides
- Somatostatin receptor agonists
- Systemic hormonal preparation stubs